LIDOCAINE 0.5%

LIDOCAINE 0.5% was reported 453 times

LIDOCAINE 0.5% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARBOXYHAEMOGLOBINAEMIA 1 0.0769
1 BENIGN DUODENAL NEOPLASM 1 0.0769
2 RADICAL NECK DISSECTION 1 0.0625
3 INJECTION SITE JOINT REDNESS 1 0.0588
4 TRIGEMINAL PALSY 2 0.0435
5 INFILTRATION ANAESTHESIA 1 0.0312
6 GASTRIC ULCER SURGERY 1 0.0250
7 PELVIC FLOOR DYSSYNERGIA 1 0.0238
8 BLOOD METHAEMOGLOBIN PRESENT 2 0.0180
9 INJECTION SITE JOINT SWELLING 1 0.0179
10 BRONCHIAL INJURY 1 0.0172
11 OROPHARYNGEAL DISCOLOURATION 1 0.0172
12 FASCIAL RUPTURE 1 0.0169
13 BRONCHOALVEOLAR LAVAGE 1 0.0164
14 MENINGEAL NEOPLASM 1 0.0149
15 DURAL TEAR 1 0.0128
16 BURKHOLDERIA INFECTION 1 0.0120
17 PLATELET AGGREGATION INHIBITION 1 0.0109
18 CENTRAL NERVOUS SYSTEM MASS 1 0.0105
19 CARDIAC INDEX DECREASED 1 0.0097
20 MONONEUROPATHY 2 0.0096
21 MENINGITIS CHEMICAL 2 0.0091
22 TOXIC ANTERIOR SEGMENT SYNDROME 8 0.0073
23 CRYPTOCOCCAL FUNGAEMIA 1 0.0070
24 FEAR-RELATED AVOIDANCE OF ACTIVITIES 1 0.0066
25 ADAMS-STOKES SYNDROME 1 0.0065
26 HERPES ZOSTER INFECTION NEUROLOGICAL 1 0.0063
27 SERUM SEROTONIN DECREASED 1 0.0063
28 PNEUMOCEPHALUS 2 0.0060
29 TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 1 0.0055
30 ENDOTRACHEAL INTUBATION COMPLICATION 3 0.0051
31 CARDIAC PROCEDURE COMPLICATION 3 0.0049
32 GRAM STAIN POSITIVE 1 0.0049
33 GENITAL DISORDER MALE 1 0.0047
34 PARALYSIS FLACCID 1 0.0046
35 NEUROMUSCULAR BLOCKADE 1 0.0045
36 ANAESTHETIC COMPLICATION 12 0.0045
37 FAMILIAL PERIODIC PARALYSIS 1 0.0044
38 ANTERIOR CHAMBER DISORDER 1 0.0043
39 TYPE IIA HYPERLIPIDAEMIA 1 0.0043
40 MENINGITIS FUNGAL 1 0.0043
41 MYCOBACTERIUM CHELONAE INFECTION 3 0.0041
42 DENTURE WEARER 1 0.0039
43 AIRWAY COMPLICATION OF ANAESTHESIA 1 0.0038
44 SYRINGOMYELIA 1 0.0036
45 WRONG PRODUCT STORED 1 0.0035
46 BURKHOLDERIA CEPACIA COMPLEX INFECTION 1 0.0035
47 MONARTHRITIS 1 0.0033
48 HAEMORRHOIDS THROMBOSED 1 0.0033
49 INTESTINAL FUNCTIONAL DISORDER 2 0.0032
50 URTICARIA GENERALISED 2 0.0031
51 INTRACRANIAL HYPOTENSION 2 0.0031
52 UNWANTED AWARENESS DURING ANAESTHESIA 1 0.0030
53 SOFT TISSUE INFLAMMATION 1 0.0030
54 JOINT ABSCESS 1 0.0029
55 SMALL CELL LUNG CANCER METASTATIC 1 0.0028
56 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 3 0.0028
57 SERUM SEROTONIN INCREASED 1 0.0028
58 ANTIDEPRESSANT DRUG LEVEL INCREASED 1 0.0028
59 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 1 0.0028
60 SOFT TISSUE HAEMORRHAGE 1 0.0027
61 CAUDA EQUINA SYNDROME 2 0.0026
62 ADMINISTRATION SITE REACTION 1 0.0026
63 PRODUCT CONTAMINATION MICROBIAL 3 0.0025
64 SPUTUM CULTURE POSITIVE 2 0.0025
65 SPINAL DECOMPRESSION 1 0.0024
66 CORONARY ARTERY ATHEROSCLEROSIS 1 0.0024
67 CORNEAL OEDEMA 5 0.0022
68 ANAESTHETIC COMPLICATION NEUROLOGICAL 2 0.0022
69 IMPLANT SITE REACTION 1 0.0022
70 RETINAL SCAR 1 0.0022
71 CHONDROLYSIS 1 0.0021
72 TUMOUR INVASION 1 0.0021
73 BRAIN STEM STROKE 1 0.0020
74 CATARACT OPERATION COMPLICATION 1 0.0020
75 TRACHEAL DISORDER 1 0.0019
76 INTERVERTEBRAL DISC DISPLACEMENT 1 0.0019
77 ACUTE INTERSTITIAL PNEUMONITIS 1 0.0019
78 ENZYME ABNORMALITY 1 0.0019
79 PRODUCT CLOSURE ISSUE 1 0.0018
80 METHAEMOGLOBINAEMIA 4 0.0017
81 SPINAL EPIDURAL HAEMATOMA 1 0.0017
82 THALAMIC INFARCTION 1 0.0017
83 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 2 0.0016
84 BLADDER IRRITATION 1 0.0016
85 ANOXIC ENCEPHALOPATHY 1 0.0016
86 IATROGENIC INJURY 2 0.0016
87 DEVICE BATTERY ISSUE 1 0.0015
88 GALLBLADDER PAIN 1 0.0015
89 INFUSION SITE URTICARIA 1 0.0015
90 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 1 0.0015
91 ARTHRITIS BACTERIAL 6 0.0015
92 SCROTAL OEDEMA 1 0.0014
93 INFECTION IN AN IMMUNOCOMPROMISED HOST 1 0.0014
94 SMALL FIBRE NEUROPATHY 1 0.0014
95 VITAMIN B COMPLEX DEFICIENCY 1 0.0013
96 BRAIN STEM SYNDROME 1 0.0013
97 CHOLANGITIS ACUTE 1 0.0013
98 REFLUX OESOPHAGITIS 1 0.0013
99 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
100 LABORATORY TEST INTERFERENCE 1 0.0013
101 OPHTHALMOPLEGIA 2 0.0013
102 ELECTROMECHANICAL DISSOCIATION 1 0.0013
103 CHEMICAL INJURY 1 0.0012
104 ANAL ULCER 1 0.0012
105 PERIORBITAL HAEMATOMA 1 0.0012
106 AMAUROSIS 1 0.0012
107 COLONIC ABSCESS 1 0.0012
108 INJECTION SITE OEDEMA 2 0.0012
109 ADENOMA BENIGN 1 0.0012
110 RECALLED PRODUCT 2 0.0012
111 SPINAL CORD INJURY 2 0.0011
112 MUSCLE SWELLING 1 0.0011
113 EXTENSOR PLANTAR RESPONSE 1 0.0011
114 HAEMOCHROMATOSIS 1 0.0011
115 PRODUCT APPEARANCE CONFUSION 1 0.0011
116 DELAYED RECOVERY FROM ANAESTHESIA 1 0.0011
117 CEREBELLAR ATAXIA 1 0.0010
118 MATERNAL EXPOSURE DURING DELIVERY 1 0.0010
119 HEMIANOPIA 1 0.0010
120 CREPITATIONS 3 0.0010
121 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
122 BRAIN STEM INFARCTION 1 0.0010
123 CONJUNCTIVAL OEDEMA 1 0.0010
124 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
125 NEUROMYOPATHY 1 0.0009
126 ABSCESS LIMB 4 0.0009
127 INFUSION SITE MASS 1 0.0009
128 OCULAR TOXICITY 1 0.0009
129 NEPHROSCLEROSIS 1 0.0009
130 OPEN WOUND 1 0.0009
131 CATHETER RELATED COMPLICATION 1 0.0009
132 VITH NERVE PARALYSIS 1 0.0009
133 PUPILS UNEQUAL 1 0.0009
134 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
135 SICK SINUS SYNDROME 1 0.0009
136 ADMINISTRATION SITE PAIN 1 0.0009
137 PROGRESSIVE MULTIPLE SCLEROSIS 1 0.0009
138 AORTIC THROMBOSIS 1 0.0009
139 RECTAL ULCER 1 0.0009
140 HYPERTENSIVE EMERGENCY 1 0.0008
141 PRETERM PREMATURE RUPTURE OF MEMBRANES 1 0.0008
142 CHRONIC RESPIRATORY FAILURE 1 0.0008
143 PANCREATIC NEOPLASM 1 0.0008
144 INTRA-ABDOMINAL HAEMATOMA 1 0.0008
145 BREECH PRESENTATION 1 0.0008
146 NEUTROPHIL PERCENTAGE INCREASED 1 0.0008
147 LIP DISCOLOURATION 1 0.0008
148 EXCORIATION 2 0.0008
149 BRONCHIAL SECRETION RETENTION 1 0.0008
150 PROCEDURAL COMPLICATION 6 0.0008
151 FEELINGS OF WORTHLESSNESS 1 0.0008
152 INTESTINAL MASS 1 0.0007
153 PELVIC VENOUS THROMBOSIS 1 0.0007
154 FOOT AMPUTATION 1 0.0007
155 NODAL RHYTHM 1 0.0007
156 HYPERTHERMIA MALIGNANT 1 0.0007
157 IMPETIGO 1 0.0007
158 ENDOPHTHALMITIS 4 0.0007
159 ADHESION 1 0.0007
160 HEAT STROKE 1 0.0007
161 INFECTIOUS PLEURAL EFFUSION 1 0.0007
162 MYOGLOBIN BLOOD INCREASED 1 0.0007
163 INJECTION SITE PARAESTHESIA 1 0.0007
164 CRYPTOCOCCOSIS 1 0.0006
165 DENTAL IMPLANTATION 1 0.0006
166 THROMBOSIS IN DEVICE 2 0.0006
167 INJECTION RELATED REACTION 1 0.0006
168 QUADRIPARESIS 1 0.0006
169 DRUG TOXICITY 8 0.0006
170 PRODUCT COUNTERFEIT 1 0.0006
171 VASCULAR PSEUDOANEURYSM 1 0.0006
172 MENINGITIS CRYPTOCOCCAL 1 0.0006
173 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
174 TYPE I HYPERSENSITIVITY 2 0.0006
175 MUSCLE CRAMP 1 0.0006
176 PARAPARESIS 1 0.0006
177 CARDIAC ABLATION 1 0.0006
178 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
179 OPHTHALMIC HERPES ZOSTER 1 0.0006
180 ESSENTIAL HYPERTENSION 1 0.0005
181 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
182 BLOOD BICARBONATE DECREASED 1 0.0005
183 MYELOPATHY 1 0.0005
184 HYPOREFLEXIA 1 0.0005
185 TRAUMATIC LUNG INJURY 1 0.0005
186 ATROPHY 1 0.0005
187 DIPLEGIA 1 0.0005
188 CORONARY ARTERY THROMBOSIS 1 0.0005
189 SINUS TACHYCARDIA 7 0.0005
190 VASCULAR STENT THROMBOSIS 1 0.0005
191 INJECTION SITE NECROSIS 1 0.0005
192 QUADRIPLEGIA 1 0.0005
193 POST PROCEDURAL COMPLICATION 9 0.0005
194 OCULOGYRIC CRISIS 1 0.0005
195 HYPERPHOSPHATAEMIA 1 0.0005
196 EXOPHTHALMOS 1 0.0005
197 NOSOCOMIAL INFECTION 1 0.0005
198 BACTERIAL TEST POSITIVE 1 0.0004
199 PERIARTHRITIS 1 0.0004
200 BRAIN OPERATION 1 0.0004
201 EYELID DISORDER 1 0.0004
202 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
203 ORAL SURGERY 1 0.0004
204 CONTRAST MEDIA REACTION 1 0.0004
205 LONG QT SYNDROME 1 0.0004
206 PRODUCT PACKAGING CONFUSION 1 0.0004
207 BRONCHITIS CHRONIC 1 0.0004
208 DERMAL CYST 1 0.0004
209 DENTAL OPERATION 1 0.0004
210 PENIS DISORDER 1 0.0004
211 INJECTION SITE ABSCESS 1 0.0004
212 TACHYARRHYTHMIA 1 0.0004
213 CATHETER SITE HAEMORRHAGE 1 0.0004
214 RETINAL ARTERY OCCLUSION 1 0.0004
215 ENDODONTIC PROCEDURE 1 0.0004
216 HERNIA REPAIR 1 0.0004
217 PHARMACEUTICAL PRODUCT COMPLAINT 10 0.0004
218 HEPATITIS TOXIC 1 0.0004
219 INJECTION SITE DISCHARGE 2 0.0004
220 GASTRIC PERFORATION 1 0.0004
221 HYPERAESTHESIA 3 0.0004
222 SERUM SICKNESS 1 0.0004
223 LUNG CONSOLIDATION 1 0.0004
224 DIABETIC COMA 1 0.0004
225 ACUTE PULMONARY OEDEMA 2 0.0004
226 HYPERTONIA 2 0.0003
227 PARAPLEGIA 1 0.0003
228 HAEMOTHORAX 1 0.0003
229 EYELID OEDEMA 4 0.0003
230 STRESS CARDIOMYOPATHY 2 0.0003
231 PRODUCT LABEL CONFUSION 2 0.0003
232 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
233 LUMBAR SPINAL STENOSIS 1 0.0003
234 STRIDOR 1 0.0003
235 ENERGY INCREASED 2 0.0003
236 WRONG DRUG ADMINISTERED 3 0.0003
237 INFUSION SITE REACTION 1 0.0003
238 BLOOD CULTURE POSITIVE 1 0.0003
239 REBOUND ACID HYPERSECRETION 1 0.0003
240 MUSCLE SPASTICITY 4 0.0003
241 FIBROSIS 1 0.0003
242 INVESTIGATION 1 0.0003
243 RESPIRATORY RATE DECREASED 1 0.0003
244 INFUSION SITE PRURITUS 1 0.0003
245 PORTAL VEIN THROMBOSIS 1 0.0003
246 LIVER ABSCESS 1 0.0003
247 HYPOVENTILATION 1 0.0003
248 INJECTION SITE INFECTION 1 0.0003
249 INFUSION SITE HAEMORRHAGE 1 0.0003
250 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
251 MENINGITIS 2 0.0003
252 EYELID PTOSIS 3 0.0003
253 DRY THROAT 3 0.0003
254 PRODUCT LABEL ISSUE 2 0.0003
255 ECCHYMOSIS 2 0.0003
256 LEFT VENTRICULAR FAILURE 1 0.0003
257 GRANULOMA 1 0.0003
258 EXTRASYSTOLES 2 0.0003
259 LOGORRHOEA 1 0.0003
260 THERMAL BURN 2 0.0003
261 RETINAL HAEMORRHAGE 2 0.0003
262 APPARENT DEATH 1 0.0003
263 DIPLOPIA 7 0.0003
264 NEURODERMATITIS 1 0.0003
265 PARANASAL SINUS DISCOMFORT 1 0.0003
266 DERMATITIS CONTACT 3 0.0003
267 CLAVICLE FRACTURE 1 0.0003
268 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
269 CARDIOPULMONARY FAILURE 1 0.0003
270 TORSADE DE POINTES 2 0.0003
271 RESPIRATORY ACIDOSIS 1 0.0003
272 SKIN ODOUR ABNORMAL 1 0.0003
273 CANDIDIASIS 1 0.0002
274 POST PROCEDURAL INFECTION 2 0.0002
275 VENTRICULAR TACHYCARDIA 4 0.0002
276 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
277 INFUSION SITE ERYTHEMA 2 0.0002
278 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
279 FACIAL PARALYSIS 2 0.0002
280 PSEUDOMONAS INFECTION 2 0.0002
281 TEARFULNESS 1 0.0002
282 METASTATIC NEOPLASM 1 0.0002
283 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
284 LUNG INFILTRATION 2 0.0002
285 ABDOMINAL ABSCESS 1 0.0002
286 RESPIRATORY RATE INCREASED 2 0.0002
287 PAPILLOEDEMA 1 0.0002
288 DRUG EFFECT DELAYED 1 0.0002
289 GRAND MAL CONVULSION 2 0.0002
290 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
291 NEPHROGENIC ANAEMIA 1 0.0002
292 ARTHRITIS INFECTIVE 1 0.0002
293 HEPATIC STEATOSIS 4 0.0002
294 MULTIPLE MYELOMA 1 0.0002
295 PERFORMANCE STATUS DECREASED 1 0.0002
296 STAPHYLOCOCCAL INFECTION 7 0.0002
297 SKIN ABRASION 1 0.0002
298 BRONCHOSPASM 3 0.0002
299 GESTATIONAL DIABETES 1 0.0002
300 CARDIOGENIC SHOCK 3 0.0002
301 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
302 APHAGIA 1 0.0002
303 VULVOVAGINAL PAIN 1 0.0002
304 HUMERUS FRACTURE 1 0.0002
305 ATELECTASIS 2 0.0002
306 GUILLAIN-BARRE SYNDROME 1 0.0002
307 BREATH SOUNDS ABNORMAL 1 0.0002
308 STAPHYLOCOCCAL SEPSIS 1 0.0002
309 HOSPICE CARE 2 0.0002
310 BLADDER DISORDER 2 0.0002
311 ABDOMINAL TENDERNESS 1 0.0002
312 PROTEIN URINE PRESENT 1 0.0002
313 HEPATIC ENZYME ABNORMAL 1 0.0002
314 CORONARY ARTERY STENOSIS 1 0.0002
315 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
316 TOE AMPUTATION 1 0.0002
317 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 1 0.0002
318 PHARYNGEAL OEDEMA 3 0.0002
319 FOETAL DEATH 1 0.0002
320 PARTIAL SEIZURES 1 0.0002
321 NYSTAGMUS 1 0.0002
322 PHARYNGOLARYNGEAL PAIN 1 0.0002
323 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
324 FOOD POISONING 1 0.0002
325 ANAL ABSCESS 1 0.0002
326 FAECALOMA 1 0.0002
327 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
328 NECROSIS 1 0.0002
329 PREMATURE LABOUR 1 0.0002
330 GENERALISED ERYTHEMA 1 0.0002
331 EXERCISE TOLERANCE DECREASED 1 0.0002
332 HYPERVENTILATION 1 0.0002
333 SKIN WARM 1 0.0002
334 CAESAREAN SECTION 2 0.0002
335 HYPERTRIGLYCERIDAEMIA 1 0.0002
336 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
337 MUSCLE RIGIDITY 2 0.0002
338 INJECTION SITE VESICLES 1 0.0002
339 NEURALGIA 4 0.0002
340 DERMATITIS ACNEIFORM 1 0.0002
341 DRUG ABUSER 1 0.0002
342 INJECTION SITE EXTRAVASATION 2 0.0002
343 SCOLIOSIS 1 0.0002
344 CHOLANGITIS 1 0.0002
345 OLIGURIA 1 0.0002
346 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
347 ILEUS 2 0.0002
348 INFUSION SITE EXTRAVASATION 1 0.0002
349 NASAL DRYNESS 1 0.0002
350 SCREAMING 1 0.0002
351 INTRAOCULAR PRESSURE INCREASED 2 0.0002
352 MYDRIASIS 2 0.0002
353 INFUSION SITE PAIN 2 0.0002
354 APPLICATION SITE VESICLES 1 0.0002
355 TENDON DISORDER 1 0.0002
356 URINARY RETENTION 5 0.0001
357 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
358 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
359 METASTASES TO LYMPH NODES 1 0.0001
360 WRONG PRODUCT ADMINISTERED 1 0.0001
361 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
362 INFARCTION 1 0.0001
363 APPLICATION SITE RASH 2 0.0001
364 DEFAECATION URGENCY 1 0.0001
365 HALLUCINATION, VISUAL 3 0.0001
366 HYPOXIA 5 0.0001
367 RETCHING 3 0.0001
368 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
369 VISUAL FIELD DEFECT 1 0.0001
370 GASTROENTERITIS 2 0.0001
371 APPLICATION SITE PAIN 3 0.0001
372 SENSITIVE SKIN 1 0.0001
373 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
374 RESPIRATORY DISORDER 4 0.0001
375 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
376 APPLICATION SITE PRURITUS 3 0.0001
377 BRADYCARDIA 7 0.0001
378 HAEMODYNAMIC INSTABILITY 1 0.0001
379 ACIDOSIS 1 0.0001
380 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
381 RENAL FAILURE CHRONIC 1 0.0001
382 ATRIOVENTRICULAR BLOCK 1 0.0001
383 LUNG INFECTION 2 0.0001
384 EJECTION FRACTION DECREASED 2 0.0001
385 APNOEA 1 0.0001
386 SWOLLEN TONGUE 4 0.0001
387 GASTROINTESTINAL INFLAMMATION 1 0.0001
388 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
389 CYANOSIS 2 0.0001
390 MEDICATION ERROR 7 0.0001
391 LOW BIRTH WEIGHT BABY 1 0.0001
392 ABSCESS 2 0.0001
393 MIOSIS 1 0.0001
394 SENSORY LOSS 1 0.0001
395 RHINITIS 1 0.0001
396 MUSCLE DISORDER 1 0.0001
397 BLOOD POTASSIUM INCREASED 2 0.0001
398 DECUBITUS ULCER 1 0.0001
399 CONVULSION 7 0.0001
400 ABNORMAL FAECES 1 0.0001
401 LETHARGY 7 0.0001
402 CARDIAC ARREST 10 0.0001
403 MENSTRUAL DISORDER 1 0.0001
404 EMBOLISM 1 0.0001
405 FACE OEDEMA 2 0.0001
406 INADEQUATE ANALGESIA 1 0.0001
407 CIRCULATORY COLLAPSE 2 0.0001
408 SCAR 2 0.0001
409 CARDIAC OPERATION 1 0.0001
410 ANURIA 1 0.0001
411 SKIN ULCER 3 0.0001
412 BLOOD MAGNESIUM DECREASED 1 0.0001
413 MULTI-ORGAN FAILURE 2 0.0001
414 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
415 APPLICATION SITE ERYTHEMA 3 0.0001
416 NEUROTOXICITY 2 0.0001
417 GROIN PAIN 1 0.0001
418 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
419 GOUT 2 0.0001
420 LOSS OF LIBIDO 1 0.0001
421 ANAL INCONTINENCE 1 0.0001
422 CRYING 4 0.0001
423 END STAGE RENAL DISEASE 2 0.0001
424 EXOSTOSIS 1 0.0001
425 ACCIDENTAL OVERDOSE 4 0.0001
426 RESPIRATORY ARREST 3 0.0001
427 OXYGEN SATURATION DECREASED 6 0.0001
428 PHOTOPHOBIA 2 0.0001
429 LACERATION 1 0.0001
430 DYSARTHRIA 4 0.0001
431 SQUAMOUS CELL CARCINOMA 1 0.0001
432 RECALLED PRODUCT ADMINISTERED 1 0.0001
433 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
434 SEROTONIN SYNDROME 2 0.0001
435 DYSTONIA 2 0.0001
436 AUTOIMMUNE DISORDER 1 0.0001
437 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
438 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
439 THERAPY CHANGE 1 0.0001
440 INABILITY TO AFFORD MEDICATION 1 0.0001
441 PERITONITIS BACTERIAL 1 0.0001
442 MOTOR DYSFUNCTION 1 0.0001
443 THERAPY CESSATION 5 0.0001
444 VENTRICULAR EXTRASYSTOLES 1 0.0001
445 PULMONARY HYPERTENSION 2 0.0001
446 TENDERNESS 1 0.0001
447 WEIGHT FLUCTUATION 1 0.0001
448 AGITATION 7 0.0001
449 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
450 JOINT DISLOCATION 1 0.0001
451 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
452 IMPAIRED WORK ABILITY 2 0.0001
453 DRUG EFFECT DECREASED 5 0.0001
454 OSTEONECROSIS 3 0.0001
455 ASPIRATION 1 0.0001
456 VISUAL ACUITY REDUCED 3 0.0001
457 VENTRICULAR FIBRILLATION 1 0.0001
458 NERVE INJURY 1 0.0001
459 HYPOTENSION 18 0.0001
460 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
461 SINUSITIS 9 0.0001
462 SCAB 1 0.0001
463 MICTURITION URGENCY 1 0.0001
464 MUSCLE TWITCHING 2 0.0001
465 ELECTROLYTE IMBALANCE 1 0.0001
466 BACTERAEMIA 1 0.0001
467 ATAXIA 1 0.0001
468 PRODUCT ADHESION ISSUE 3 0.0001
469 THYROID CANCER 1 0.0001
470 LOCALISED INFECTION 2 0.0001
471 ADRENAL INSUFFICIENCY 1 0.0001
472 FIBROMYALGIA 2 0.0001
473 PRESYNCOPE 2 0.0001
474 NO THERAPEUTIC RESPONSE 1 0.0001
475 ENCEPHALOPATHY 2 0.0001
476 CARDIOMEGALY 1 0.0001
477 HYPERCALCAEMIA 1 0.0001
478 INJECTION SITE DISCOLOURATION 1 0.0001
479 BRAIN OEDEMA 1 0.0001
480 MUSCLE ATROPHY 1 0.0001
481 INJECTION SITE IRRITATION 1 0.0001
482 ROTATOR CUFF SYNDROME 1 0.0001
483 ANOREXIA 1 0.0001
484 ANAPHYLACTIC SHOCK 2 0.0001
485 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
486 UNRESPONSIVE TO STIMULI 2 0.0001
487 HIATUS HERNIA 1 0.0001
488 NODULE 1 0.0001
489 GASTRITIS 2 0.0001
490 TOOTH INFECTION 1 0.0001
491 PULMONARY CONGESTION 1 0.0001
492 EAR INFECTION 2 0.0001
493 QUALITY OF LIFE DECREASED 1 0.0001
494 SINUS CONGESTION 1 0.0001
495 PALLOR 2 0.0001
496 PERIPHERAL COLDNESS 1 0.0001
497 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
498 HAEMATOCHEZIA 4 0.0001
499 POLLAKIURIA 3 0.0001
500 COORDINATION ABNORMAL 1 0.0001
501 MASS 1 0.0001
502 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
503 SKIN REACTION 1 0.0001
504 BLINDNESS UNILATERAL 1 0.0001
505 HEPATOCELLULAR INJURY 1 0.0001
506 PARALYSIS 1 0.0001
507 PARAESTHESIA ORAL 1 0.0001
508 HYPOKINESIA 1 0.0001
509 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
510 CARDIOMYOPATHY 1 0.0001
511 URINARY INCONTINENCE 2 0.0001
512 RENAL INJURY 2 0.0001
513 PULMONARY MASS 1 0.0001
514 PULMONARY OEDEMA 3 0.0001
515 THROAT IRRITATION 3 0.0001
516 BLOOD POTASSIUM DECREASED 2 0.0001
517 HYPOAESTHESIA ORAL 1 0.0001
518 APHASIA 2 0.0001
519 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
520 DRUG DISPENSING ERROR 1 0.0001
521 INSURANCE ISSUE 1 0.0001
522 HIP ARTHROPLASTY 1 0.0001
523 INJECTION SITE RASH 2 0.0001
524 ANKLE FRACTURE 1 0.0001
525 BASAL CELL CARCINOMA 1 0.0001
526 PRODUCT USE COMPLAINT 1 0.0001
527 DRUG INTERACTION 10 0.0001
528 PREMATURE DELIVERY 1 0.0001
529 OBESITY 1 0.0001
530 METABOLIC ACIDOSIS 2 0.0001
531 SENSORY DISTURBANCE 1 0.0001
532 MOVEMENT DISORDER 2 0.0001
533 NIGHT SWEATS 2 0.0001
534 MUSCLE TIGHTNESS 1 0.0001
535 DRY MOUTH 5 0.0001
536 SWELLING FACE 4 0.0001
537 IMPAIRED HEALING 2 0.0001
538 SEIZURE 7 0.0001
539 HEART RATE INCREASED 6 0.0001
540 BLOOD UREA INCREASED 1 0.0001
541 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
542 DISEASE PROGRESSION 7 0.0001
543 HEMIPARESIS 1 0.0001
544 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
545 INFLAMMATION 3 0.0001
546 ORTHOSTATIC HYPOTENSION 1 0.0001
547 LOCAL SWELLING 1 0.0001
548 MUSCULOSKELETAL PAIN 3 0.0001
549 BURNING SENSATION 4 0.0001
550 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
551 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
552 ISCHAEMIC STROKE 1 0.0001
553 GALLBLADDER DISORDER 1 0.0001
554 OSTEOMYELITIS 1 0.0001
555 HYPERGLYCAEMIA 2 0.0001
556 BONE DISORDER 1 0.0001
557 LOSS OF CONSCIOUSNESS 7 0.0001
558 ANAPHYLACTIC REACTION 3 0.0001
559 SEPSIS 6 0.0001
560 BACTERIAL INFECTION 1 0.0001
561 CARDIAC DISORDER 5 0.0001
562 COLITIS 2 0.0001
563 BLOOD URINE PRESENT 1 0.0001
564 GASTRIC ULCER 1 0.0001
565 PROTEINURIA 1 0.0001
566 FEELING JITTERY 1 0.0001
567 SLEEP APNOEA SYNDROME 1 0.0001
568 CHOLESTASIS 1 0.0001
569 DRUG PRESCRIBING ERROR 1 0.0001
570 ACUTE RESPIRATORY FAILURE 1 0.0001
571 HERNIA 1 0.0001
572 ERUCTATION 1 0.0001
573 PRODUCT QUALITY ISSUE 7 0.0001
574 ATRIAL FIBRILLATION 5 0.0001
575 SINUS DISORDER 1 0.0001
576 DISORIENTATION 2 0.0001
577 SPINAL FRACTURE 1 0.0000
578 FEEDING DISORDER 1 0.0000
579 TASTE DISORDER 1 0.0000
580 VERTIGO 3 0.0000
581 BODY TEMPERATURE INCREASED 1 0.0000
582 PRODUCT PREPARATION ERROR 1 0.0000
583 ERYTHEMA 10 0.0000
584 RIB FRACTURE 1 0.0000
585 INJECTION SITE WARMTH 1 0.0000
586 ABDOMINAL PAIN UPPER 10 0.0000
587 PERITONITIS 1 0.0000
588 RHABDOMYOLYSIS 2 0.0000
589 MOUTH ULCERATION 1 0.0000
590 GAIT DISTURBANCE 9 0.0000
591 IRRITABLE BOWEL SYNDROME 1 0.0000
592 HYPERHIDROSIS 6 0.0000
593 HYPOACUSIS 2 0.0000
594 PRURITUS GENERALISED 1 0.0000
595 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
596 SEPTIC SHOCK 2 0.0000
597 BLOOD CREATININE INCREASED 3 0.0000
598 BLOOD PRESSURE INCREASED 7 0.0000
599 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
600 MUSCULOSKELETAL STIFFNESS 4 0.0000
601 FEBRILE NEUTROPENIA 3 0.0000
602 BLOOD PRESSURE DECREASED 3 0.0000
603 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
604 TACHYCARDIA 4 0.0000
605 TOOTH DISORDER 1 0.0000
606 ORAL PAIN 1 0.0000
607 SNEEZING 1 0.0000
608 PARAESTHESIA 7 0.0000
609 PANCREATITIS ACUTE 1 0.0000
610 HEART RATE IRREGULAR 1 0.0000
611 MUSCULAR WEAKNESS 5 0.0000
612 SKIN IRRITATION 2 0.0000
613 MUSCLE SPASMS 8 0.0000
614 TINNITUS 2 0.0000
615 SKIN DISCOLOURATION 2 0.0000
616 SHOCK 1 0.0000
617 PERICARDIAL EFFUSION 1 0.0000
618 CHEST PAIN 8 0.0000
619 HYPERSENSITIVITY 8 0.0000
620 COGNITIVE DISORDER 2 0.0000
621 PALPITATIONS 5 0.0000
622 ARRHYTHMIA 2 0.0000
623 TREMOR 7 0.0000
624 DYSPHAGIA 4 0.0000
625 COMA 2 0.0000
626 RASH ERYTHEMATOUS 2 0.0000
627 MULTIPLE SCLEROSIS 2 0.0000
628 URTICARIA 7 0.0000
629 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
630 TOXICITY TO VARIOUS AGENTS 7 0.0000
631 INTERSTITIAL LUNG DISEASE 2 0.0000
632 INJECTION SITE URTICARIA 1 0.0000
633 PAIN 25 0.0000
634 BRONCHITIS 3 0.0000
635 PYREXIA 14 0.0000
636 NAUSEA 32 0.0000
637 INJECTION SITE ERYTHEMA 5 0.0000
638 DIZZINESS 20 0.0000
639 PNEUMONIA ASPIRATION 1 0.0000
640 CELLULITIS 2 0.0000
641 HAEMATEMESIS 1 0.0000
642 FLUSHING 4 0.0000
643 INJECTION SITE SWELLING 3 0.0000
644 HEPATITIS 1 0.0000
645 BACK PAIN 9 0.0000
646 RASH GENERALISED 1 0.0000
647 ABDOMINAL DISTENSION 4 0.0000
648 VOMITING 18 0.0000
649 NERVOUSNESS 2 0.0000
650 MUCOSAL INFLAMMATION 1 0.0000
651 SEDATION 1 0.0000
652 SPEECH DISORDER 2 0.0000
653 ARTHRITIS 3 0.0000
654 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
655 PAIN OF SKIN 1 0.0000
656 CONFUSIONAL STATE 6 0.0000
657 DISTURBANCE IN ATTENTION 2 0.0000
658 THROAT TIGHTNESS 1 0.0000
659 RASH PRURITIC 2 0.0000
660 OEDEMA 2 0.0000
661 HEADACHE 23 0.0000
662 MOOD ALTERED 1 0.0000
663 INFLUENZA LIKE ILLNESS 3 0.0000
664 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
665 RESPIRATORY DISTRESS 1 0.0000
666 DIVERTICULITIS 1 0.0000
667 PROCEDURAL PAIN 1 0.0000
668 MENTAL STATUS CHANGES 1 0.0000
669 FEELING COLD 1 0.0000
670 INFLUENZA 4 0.0000
671 PANCYTOPENIA 2 0.0000
672 NECK PAIN 2 0.0000
673 SKIN EXFOLIATION 3 0.0000
674 HYPERSOMNIA 1 0.0000
675 BALANCE DISORDER 3 0.0000
676 PANCREATIC CARCINOMA 1 0.0000
677 LIVER FUNCTION TEST ABNORMAL 1 0.0000
678 DYSSTASIA 1 0.0000
679 CHILLS 4 0.0000
680 ACUTE MYOCARDIAL INFARCTION 1 0.0000
681 LABORATORY TEST ABNORMAL 1 0.0000
682 WHEEZING 2 0.0000
683 HYPOAESTHESIA 5 0.0000
684 PREMATURE BABY 1 0.0000
685 HEPATIC FAILURE 1 0.0000
686 LACRIMATION INCREASED 1 0.0000
687 HYPERTENSION 7 0.0000
688 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
689 CORONARY ARTERY DISEASE 1 0.0000
690 PLEURAL EFFUSION 2 0.0000
691 INJECTION SITE PAIN 10 0.0000
692 DRUG ADMINISTRATION ERROR 1 0.0000
693 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
694 EXPOSURE DURING PREGNANCY 2 0.0000
695 CYSTITIS 1 0.0000
696 EYE DISORDER 1 0.0000
697 EXPIRED PRODUCT ADMINISTERED 1 0.0000
698 VIRAL INFECTION 1 0.0000
699 FUNGAL INFECTION 1 0.0000
700 SYNCOPE 3 0.0000
701 GAIT INABILITY 1 0.0000
702 INJECTION SITE PRURITUS 2 0.0000
703 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
704 FEELING ABNORMAL 7 0.0000
705 GASTRIC DISORDER 1 0.0000
706 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
707 INJECTION SITE REACTION 2 0.0000
708 DELIRIUM 1 0.0000
709 HEART RATE DECREASED 1 0.0000
710 SLEEP DISORDER 2 0.0000
711 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
712 OVERDOSE 6 0.0000
713 INFECTION 4 0.0000
714 PANIC ATTACK 1 0.0000
715 RESPIRATORY FAILURE 2 0.0000
716 DYSURIA 1 0.0000
717 FALL 9 0.0000
718 DYSGEUSIA 2 0.0000
719 THROMBOCYTOPENIA 3 0.0000
720 ASTHENIA 10 0.0000
721 DYSPNOEA EXERTIONAL 1 0.0000
722 ASTHMA 3 0.0000
723 UNEVALUABLE EVENT 2 0.0000
724 PERIPHERAL SWELLING 4 0.0000
725 PLASMA CELL MYELOMA 1 0.0000
726 SOMNOLENCE 5 0.0000
727 BLINDNESS 1 0.0000
728 LUNG NEOPLASM MALIGNANT 1 0.0000
729 CARDIO-RESPIRATORY ARREST 1 0.0000
730 ROAD TRAFFIC ACCIDENT 1 0.0000
731 PAIN IN EXTREMITY 7 0.0000
732 DRUG INEFFECTIVE 31 0.0000
733 URINARY TRACT INFECTION 4 0.0000
734 PRURITUS 9 0.0000
735 RECTAL HAEMORRHAGE 1 0.0000
736 DEVICE DISLOCATION 1 0.0000
737 MENTAL DISORDER 1 0.0000
738 CONSTIPATION 5 0.0000
739 ANGIOEDEMA 1 0.0000
740 RENAL FAILURE 3 0.0000
741 DRY SKIN 3 0.0000
742 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
743 VISION BLURRED 3 0.0000
744 HYPOKALAEMIA 1 0.0000
745 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
746 PNEUMONIA 7 0.0000
747 OROPHARYNGEAL PAIN 2 0.0000
748 WEIGHT DECREASED 6 0.0000
749 BLOOD CHOLESTEROL INCREASED 1 0.0000
750 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
751 COUGH 6 0.0000
752 OCULAR HYPERAEMIA 1 0.0000
753 PULMONARY EMBOLISM 2 0.0000
754 DISEASE RECURRENCE 1 0.0000
755 PRODUCTIVE COUGH 1 0.0000
756 CONTUSION 2 0.0000
757 HYPOGLYCAEMIA 1 0.0000
758 OFF LABEL USE 18 0.0000
759 ALOPECIA 4 0.0000
760 DYSPEPSIA 2 0.0000
761 DRY EYE 1 0.0000
762 LEUKOPENIA 1 0.0000
763 FATIGUE 15 0.0000
764 ECZEMA 1 0.0000
765 ARTHROPATHY 1 0.0000
766 BLISTER 1 0.0000
767 EYE PAIN 1 0.0000
768 CEREBROVASCULAR ACCIDENT 3 0.0000
769 DYSPNOEA 10 0.0000
770 FLATULENCE 1 0.0000
771 PRODUCT SUBSTITUTION ISSUE 1 0.0000
772 DECREASED APPETITE 4 0.0000
773 BONE PAIN 1 0.0000
774 SURGERY 1 0.0000
775 NASAL CONGESTION 1 0.0000
776 IRRITABILITY 1 0.0000
777 JOINT SWELLING 2 0.0000
778 STOMATITIS 1 0.0000
779 CONDITION AGGRAVATED 5 0.0000
780 OEDEMA PERIPHERAL 2 0.0000
781 FEELING HOT 1 0.0000
782 NASOPHARYNGITIS 3 0.0000
783 INFUSION RELATED REACTION 1 0.0000
784 NEUTROPENIA 2 0.0000
785 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
786 MEMORY IMPAIRMENT 2 0.0000
787 ARTHRALGIA 6 0.0000
788 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
789 ANXIETY 4 0.0000
790 THERAPY INTERRUPTED 1 0.0000
791 SKIN BURNING SENSATION 1 0.0000
792 DIARRHOEA 9 0.0000
793 RASH 6 0.0000
794 EPISTAXIS 1 0.0000
795 HALLUCINATION 1 0.0000
796 CHRONIC KIDNEY DISEASE 1 0.0000
797 INCORRECT DOSE ADMINISTERED 3 0.0000
798 ACUTE KIDNEY INJURY 2 0.0000
799 HOSPITALISATION 2 0.0000
800 ABDOMINAL PAIN 3 0.0000
801 CARDIAC FAILURE 1 0.0000
802 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
803 ABDOMINAL DISCOMFORT 2 0.0000
804 MYOCARDIAL INFARCTION 2 0.0000
805 DRUG WITHDRAWAL SYNDROME 1 0.0000
806 INSOMNIA 3 0.0000
807 DEVICE ISSUE 1 0.0000
808 ADVERSE DRUG REACTION 1 0.0000
809 NO ADVERSE EVENT 2 0.0000
810 ADVERSE EVENT 1 0.0000
811 SWELLING 1 0.0000
812 MIGRAINE 1 0.0000
813 DRUG INTOLERANCE 1 0.0000
814 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
815 CHEST DISCOMFORT 1 0.0000
816 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
817 HAEMOGLOBIN DECREASED 1 0.0000
818 ILLNESS 1 0.0000
819 HAEMORRHAGE 1 0.0000
820 PLATELET COUNT DECREASED 1 0.0000
821 DEATH 8 0.0000
822 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
823 MALAISE 4 0.0000
824 DEHYDRATION 1 0.0000
825 DRUG DOSE OMISSION 1 0.0000
826 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
827 PRODUCT USE ISSUE 1 0.0000
828 BLOOD GLUCOSE INCREASED 1 0.0000
829 ANAEMIA 1 0.0000
830 WEIGHT INCREASED 1 0.0000
831 DEPRESSION 1 0.0000